Clinical Trials/SLCTR/2017/011

SLCTR/2017/011

Recruiting

N/A

Improving health and well-being of elderly patients from a tertiary care hospital through nurse-led discharge plan and follow-up care: a Randomised Controlled Trial

niversity of Sri Jayewardenepura0 sitesTBD

ConditionsWell-being in the elderly

Overview

Phase: N/A
Intervention: Not specified
Conditions: Well-being in the elderly
Sponsor: niversity of Sri Jayewardenepura
Status: Recruiting
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

last year

Study Type

Interventional

Investigators

Sponsor

niversity of Sri Jayewardenepura

Eligibility Criteria

Inclusion Criteria

•1\. Male and female elderly patients (60 years or above)
•2\. Needing follow up care and having caregivers (any family member, relative, neighbor, or friend who is willing and capable of looking after elderly person in the home)

Exclusion Criteria

•1\. Terminally ill
•2\. No caregiver
•3\. Declined to participate

Outcomes

Primary Outcomes

Not specified

Similar Trials

Creating health for elderly people making full use of regional characteristicsPsychological distress

JPRN-UMIN000036003aruto University of Education40

Not Yet Recruiting

Trial for improving health outcomes among older adults in India using comprehensive assessment

CTRI/2023/07/055661Dr Jaya Singh Kshatri

Developing better care for the elderly patients with walking disability due to degenerative lumbar spine stenosis

ISRCTN35836727Record Provided by the NHSTCT Register - 2006 Update - Department of Health20

Active, Not Recruiting

Improvement of Outcome in Elderly Patients or Patients not eligible for high-dose chemotherapy with Aggressive Non-Hodgkin Lymphoma in first Relapse or Progression by adding Nivolumab to a standard chemotherapy.

EUCTR2016-002272-27-BESaarland University388

Active, Not Recruiting

Improvement of Outcome in Elderly Patients or Patients not eligible for high-dose chemotherapy with Aggressive Non-Hodgkin Lymphoma in first Relapse or Progression by adding Nivolumab to a standard chemotherapy.Patients with first relapse or progression of aggressive Non-Hodgkin’s Lymphoma who are not eligible neither for autologous nor allogeneic stem cell transplantationMedDRA version: 22.0Level: PTClassification code 10029547Term: Non-Hodgkin's lymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]

EUCTR2016-002272-27-ATSaarland University388